Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | -0.06% | 81.12 | 0.7% | $1566.02m | |
| JNJ | Johnson & Johnson | 0.19% | 163.71 | 0.7% | $997.82m | |
| PFE | Pfizer Inc. | 0.77% | 43.19 | 0.9% | $901.42m | |
| ABBV | AbbVie, Inc. | 0.42% | 109.22 | 1.9% | $661.78m | |
| BMY | Bristol-Myers Squibb Co. | -0.38% | 57.59 | 1.0% | $625.23m | |
| LLY | Eli Lilly & Co. | 1.07% | 243.75 | 1.1% | $585.84m | |
| AZN | AstraZeneca Plc | 0.93% | 61.79 | 1.0% | $310.35m | |
| NVS | Novartis AG | 0.31% | 84.93 | 0.2% | $174.90m | |
| GSK | GlaxoSmithKline Plc | 0.58% | 39.78 | 0.2% | $162.05m | |
| AVIR | Atea Pharmaceuticals, Inc. | -0.16% | 12.73 | 0.3% | $125.28m | |
| RGEN | Repligen Corp. | 1.55% | 274.95 | 6.8% | $113.28m | |
| NVO | Novo Nordisk A/S | 1.51% | 105.99 | 0.1% | $89.92m | |
| VTRS | Viatris, Inc. | -0.50% | 13.94 | 0.0% | $87.91m | |
| SNY | Sanofi | 1.44% | 49.92 | 0.2% | $70.53m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 2.27% | 139.98 | 0.0% | $52.50m |
Company Profile
Royalty Pharma Plc provides drug development services. The firm operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.